<DOC>
	<DOC>NCT01086774</DOC>
	<brief_summary>Evaluation of the optical effects of Systane Ultra</brief_summary>
	<brief_title>Efficacy of Systane Balance to Stabilize the Tear Film in Dry Eye Subjects</brief_title>
	<detailed_description />
	<mesh_term>Keratoconjunctivitis Sicca</mesh_term>
	<mesh_term>Dry Eye Syndromes</mesh_term>
	<mesh_term>Ophthalmic Solutions</mesh_term>
	<mesh_term>Tetrahydrozoline</mesh_term>
	<mesh_term>Lubricant Eye Drops</mesh_term>
	<criteria>1. Age 18 years or more. 2. Subjects must have Tear Break Up Time (TBUT) &lt; 5 seconds 3. Subjects must have a maximum blink interval (MBI) &lt; 10 seconds 4. Subjects must be willing to comply with all study requirements. 5. Subjects must understand, sign and be given a copy of the written Informed Consent form. 1. Subjects for whom both eyes do not meet all inclusion criteria and either eye meets exclusion criteria 2. Subjects who are pregnant, lactating or planning to be pregnant during the course of the study 3. Subjects with known sensitivity to planned study concomitant medications 4. Subjects participating in any other ophthalmic drug or device clinical trial within 30 days of this clinical investigation. 5. Use of ocular drugs, other than study medications, during the study and within 14 days prior to study entry or any other ocular medication</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2012</verification_date>
	<keyword>Dry eye</keyword>
	<keyword>Tear Film Stability</keyword>
</DOC>